CRCarlos Alberto Ruiz

Carlos Alberto Ruiz

*This is an algorithmically generated author record based on publicly available information.

Carlos Alberto Ruiz has a total of 83 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    MammaPrint™ Genetic Signature in the Brazilian Population, Analysis of Results and Clinical Outcomes (AGEMA-BRA) – Real World Study

    by Fabio Postiglione Mansani, Ruffo de Freitas Junior, Wellerson de Aguiar Miranda, Antonio Carlos Buzaid, Antonio Luiz Frasson, Francisco Pimentel Cavalcante, Aaron Froede Santos, Adriana Magalhães de Oliveira Freitas, Alfredo Barros, Aline Coelho Gonçalves, et al.

    Purpose: The MammaPrint™ (MP) 70-gene signature, identifies hormone receptor-positive (HR+), HER2-negative breast cancer patients with low genomic risk who are candidates for de-escalation of the systemic therapies employed. Knowing that MP was validated in an exclusively European cohort and understanding the heterogeneity of breast tumors in different populations, we proposed a study to analyze MP performance in the Brazilian population. Methods: Retrospective, prognostic evaluation, real-world cohort study of HR+, HER2- breast cancer patients who underwent MP in Brazil from January 2016 to December 2020 (AGEMA-BRA). Results: Of the 953 patients with high clinical risk, 407 (42.7%) had high genomic risk, and 546 (57.3%) had low genomic risk to MP. In the analysis of epidemiological, clinical, and anato-mopathological data correlating high and low risk to MP, and among the subgroups with low-risk, ultra-low risk, high-risk 1 and high-risk 2, only the histological grade showed statistical significance. Distant metastasis-free survival (DMFS) was 97.8% and overall survival (OS) was 99.8% with a mean follow-up of 40.8 months, with no difference between high and low genomic risk. Conclusions: Applying the MP signature in the AGEMA-BRA cohort enabled greater chemotherapy de-escalation with better DMFS than observed in the MINDACT pivotal study. Equivalent DMFS and OS results between high and low genomic risk carriers demonstrate the appropriate selection of patients by MP to receive or not receive adjuvant chemotherapy. These data make it possible to validate the performance of the signature in the Brazilian population and confirm the importance of testing it in different populations.

  • Open Access

    Phyllodes tumors of the breast: A comprehensive review of diagnosis, treatment, and follow-up

    by Aline Rocha Donato, Rodrigo Goncalves, Jonathan Yugo Maesaka, Fernando Nalesso Aguiar, José Maria Soares, Carlos Alberto Ruiz, José Roberto Filassi, Edmund Chada Baracat


  • Breast cancer and public healthcare: survey and proposals from Brazilian Society of Mastology (SBM)

    by Augusto Tufi Hassan, Jordana de Faria Bessa, Guilherme Garcia Novita, Sandra Gioia, André Mattar, Francisco Pimentel Cavalcante, Ruffo Freitas, Carlos Alberto Ruiz

    Introduction: High rates of breast cancer mortality have been reported for patients from public healthcare, in Brazil. This study aimed to obtain a panorama of breast cancer in public healthcare, based on a questionnaire sent to breast specialists. Methods: Active members of the Brazilian Society of Mastology (SBM) were invited to participate anonymously, from Aug-Oct 2023. Possible answers ranged from “This is not a problem” to “This is a very serious, very common problem”. The primary endpoint of the study was the relative frequency of the answers. Results: Overall, 767 (44% of all SBM affiliated members) completed the questionnaire. Access to modern drugs was considered the most concerning problem, with 81.36% of respondents classifying this as “serious, frequently” or “very serious, very frequently”, followed by access to diagnostic methods (64.53%), access to breast reconstruction (60.24%), delay in starting treatment (60.11%) and access to screening (51.76%). Conclusions: This is the first study to evaluate the perceptions of breast specialists on breast cancer care within SUS. The SBM has issued considerations and proposals aimed at reestablishing a minimally adequate standard of breast cancer diagnosis and treatment in public healthcare in Brazil.

  • Open Access

    Management of early-stage triple-negative breast cancer: recommendations of a panel of experts from the Brazilian Society of Mastology

    by Ruffo Freitas-Junior, Vilmar Marques de Oliveira, Antonio Luiz Frasson, Francisco Pimentel Cavalcante, Fabio Postiglione Mansani, AndrÉ Mattar, Felipe Pereira Zerwes, Adriana Magalhães de Oliveira Freitas, Alessandra Borba Anton de Souza, Andrea P. Damin, et al.

    Triple-negative breast cancer (TNBC) is a heterogenous subtype involving different patterns of behavior and clinical course, demanding a complex, individualized sequence of treatment. The knowledge and attitudes of the affiliated members of the Brazilian Society of Mastology regarding TNBC were evaluated and a consensus regarding management and treatment was reached. Affiliates completed a survey involving 44 objective questions. In addition, a specialist meeting was held with 27 experts and 3 ad hoc consultants. The panelists completed the survey before and after brainstorming. Answers achieving 70% of agreement were considered consensual. The chi-square test was used to compare answers between panelists and affiliates and the Kappa coefficient to calculate agreement. Consensus among the panelists increased from 26 (59.1%) to 32 questions (72.7%) following brainstorming (p = 0.17), including 7/10 questions on systemic treatment. Among the affiliates, consensus was achieved for 24 questions (54.5%), resulting in moderate agreement (κ = 0.445). Neoadjuvant chemotherapy should be indicated for almost all cases (except cT1a-b N0) and should include platinum agents. When indicated, immunotherapy is part of the standard of care. The panel reaffirmed the concept of no ink on tumor as indicative of adequate margins and the possibility of sentinel lymph node biopsy for cN1 patients who become cN0 following neoadjuvant therapy. Controversies remain on combining immunotherapy with capecitabine/olaparib in pertinent cases. Expert consensus was achieved for > 70% of the questions, with moderate agreement between panelists and affiliates. Educational interventions on systemic breast cancer treatment affected decision-making in 60% of the questions.


  • Open Access

    Health Services, Socioeconomic Indicators, and Primary Care Coverage in Mortality by Lower Genital Tract and Breast Neoplasias in Brazilian Women during Reproductive and Non-Reproductive Periods

    by José Lucas Souza Ramos, Francisco Winter dos Santos Figueiredo, Lea Tami Suzuki Zuchelo, Flávia Abranches Corsetti Purcino, Fernando Adami, Rodrigo Goncalves, Carlos Alberto Ruiz, Edmund Chada Baracat, José Maria Soares Junior, Isabel Cristina Esposito Sorpreso

    Women’s health assistance at the low-complexity level is focused on the most common diseases and can be affected by primary health care coverage, particularly in areas far away from large urban centers. Thus, in this work, we aim to analyze the relationship between socioeconomic status, health care indicators, and primary care coverage in mortality from neoplasms of the lower genital tract and breast in Brazilian women during reproductive and non-reproductive periods. We conducted an ecological study at the Gynecology Discipline, Medicine School, University of São Paulo. Secondary data were collected from women according to reproductive periods and mortality data from the Mortality Information System based on International Classification of Disease—10th edition regarding breast and lower genital tract neoplasms in 2017. The health service and socioeconomic indicators were obtained from the Informatics Department of the Unified Health System and Brazilian Institute of Geography and Statistics. Our results showed that primary care coverage and health service indicators were not associated with mortality from breast cancer and the female lower genital tract, both in reproductive and non-reproductive periods. Sociodemographic indicators were found to be associated with mortality from breast cancer and the female lower genital tract, with income being associated with reproductive period (β = −0.4; 95% CI, −0.8 to −0.03) and educational level in the non-reproductive period (β = 9.7; 95% CI, 1.5 to 18.0).


  • Open Access

    Management of benign and suspicious breast lesions during the coronavirus disease pandemic: recommendations for triage and treatment

    by Flávia Abranches Corsetti Purcino, Carlos Alberto Ruiz, Isabel C.E. Sorpreso, Ana Maria Massad Costa, José Maria Soares-Júnior, Edmund Chada Baracat, José Roberto Filassi